Swoop
Communities | White Papers
Swoop
Empowering Patients: How Pharma Ads Drive Better Health Outcomes
Survey reveals 67% of patients with chronic conditions took an action after seeing treatment advertising
Swoop
iSpot and Swoop Partner to Bring Independent Measurement and Transparency to Healthcare Marketing
Privacy-complaint targeting and measurement will help pharma brands optimize reach and frequency across TV platforms
Swoop
MarTech Breakthrough Awards Name Swoop “Best AdTech Privacy Solution”
Prestigious international annual awards program recognizes standout marketing, advertising and sales technology around the world
Swoop
Swoop Appoints Sara Michael as EVP of Content at MyHealthTeam
Sara’s arrival marks a major step forward in scaling our patient-first model
Swoop
Data and Storytelling in Cannes: The New Era of Healthcare TV Advertising
A powerhouse media, pharma, and data panel shares healthcare advertising insights, experiences, and predictions
Communities | Patient Insights
Swoop
Experiences With Ruxolitinib Cream in Patients’ Own Words: A Social Listening Analysis
Objective To understand patient experiences in their own words, including the benefits and challenges of using ruxolitinib cream. Introductions Vitiligo is a chronic, autoimmune skin disease that results in patches of skin depigmentation. MyVitiligoTeam members organically share their experiences living with and managing vitiligo with one another. This study examines recent treatment conversations centered on […]
Swoop
16 Wins for MyHealthTeam at Digital Health Awards
AI-powered solutions and authentic storytelling earn top honors
Swoop
MyHealthTeam Now Hosts 11 Communities for People Living with Cancer
MyBladderCancerTeam and MyEndometrialCancer Team connect oncology patients with medically reviewed online content and support
Swoop
Beyond Age and Gender: CTV Advertising Balances Precision and Impact
Swoop EVP Business Development Kurt Robinson shares CTV strategies for pharma marketers in VAB webinar
Communities | Patient Insights
Swoop
Living With Secondary Progressive Multiple Sclerosis
Understanding the quality-of-life impact of SPMS along with patient desired outcomes can help neurologists develop the most effective approach to treating patients for whom MS is advancing.